Acadia Pharmaceuticals | ACAD - PE Price to Earnings


Acadia Pharmaceuticals reported $13.7 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
ALKERMES USD 14.9 1.11 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Corcept Therapeutics USD 94.18 30.36 Sep/2025
Eisai JPY 26.63 0.46 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Incyte USD 14.84 2.79 Dec/2025
J&J USD 23.62 0.86 Dec/2025
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Pfizer USD 14.48 5.18 Dec/2025
Prothena USD 22.11 11.37 Mar/2022
PTC Therapeutics USD 9.98 3.25 Dec/2025
Sarepta Therapeutics USD 27.27 0 Jun/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025